When Ralph Fisher, a Texas cattle rancher, set eyes on one of the worlds first cloned calves in August 1999, he didnt care what the scientists said: He knew it was his old Brahman bull, Chance, born again. About a year earlier, veterinarians at Texas A&M extracted DNA from one of Chances moles and used the sample to create a genetic double. Chance didnt live to meet his second self, but when the calf was born, Fisher christened him Second Chance, convinced he was the same animal.
Scientists cautioned Fisher that clones are more like twins than carbon copies: The two may act or even look different from one another. But as far as Fisher was concerned, Second Chance was Chance. Not only did they look identical from a certain distance, they behaved the same way as well. They ate with the same odd mannerisms; laid in the same spot in the yard. But in 2003, Second Chance attacked Fisher and tried to gore him with his horns. About 18 months later, the bull tossed Fisher into the air like an inconvenience and rammed him into the fence. Despite 80 stitches and a torn scrotum, Fisher resisted the idea that Second Chance was unlike his tame namesake, telling the radio program This American Life that I forgive him, you know?
In the two decades since Second Chance marked a genetic engineering milestone, cattle have secured a place on the front lines of biotechnology research. Today, scientists around the world are using cutting-edge technologies, from subcutaneous biosensors to specialized food supplements, in an effort to improve safety and efficiency within the $385 billion global cattle meat industry. Beyond boosting profits, their efforts are driven by an imminent climate crisis, in which cattle play a significant role, and growing concern for livestock welfare among consumers.
Gene editing stands out as the most revolutionary of these technologies. Although gene-edited cattle have yet to be granted approval for human consumption, researchers say tools like Crispr-Cas9 could let them improve on conventional breeding practices and create cows that are healthier, meatier, and less detrimental to the environment. Cows are also being given genes from the human immune system to create antibodies in the fight against Covid-19. (The genes of non-bovine livestock such as pigs and goats, meanwhile, have been hacked to grow transplantable human organs and produce cancer drugs in their milk.)
But some experts worry biotech cattle may never make it out of the barn. For one thing, theres the optics issue: Gene editing tends to grab headlines for its role in controversial research and biotech blunders. Crispr-Cas9 is often celebrated for its potential to alter the blueprint of life, but that enormous promise can become a liability in the hands of rogue and unscrupulous researchers, tempting regulatory agencies to toughen restrictions on the technologys use. And its unclear how eager the public will be to buy beef from gene-edited animals. So the question isnt just if the technology will work in developing supercharged cattle, but whether consumers and regulators will support it.
Cattle are catalysts for climate change. Livestock account for an estimated 14.5 percent of greenhouse gas emissions from human activities, of which cattle are responsible for about two thirds, according to the United Nations Food and Agriculture Organization (FAO). One simple way to address the issue is to eat less meat. But meat consumption is expected to increase along with global population and average income. A 2012 report by the FAO projected that meat production will increase by 76 percent by 2050, as beef consumption increases by 1.2 percent annually. And the United States is projected to set a record for beef production in 2021, according to the Department of Agriculture.
For Alison Van Eenennaam, an animal geneticist at the University of California, Davis, part of the answer is creating more efficient cattle that rely on fewer resources. According to Van Eenennaam, the number of dairy cows in the United States decreased from around 25 million in the 1940s to around 9 million in 2007, while milk production has increased by nearly 60 percent. Van Eenennaam credits this boost in productivity to conventional selective breeding.
You dont need to be a rocket scientist or even a mathematician to figure out that the environmental footprint or the greenhouse gases associated with a glass of milk today is about one-third of that associated with a glass of milk in the 1940s, she says. Anything you can do to accelerate the rate of conventional breeding is going to reduce the environmental footprint of a glass of milk or a pound of meat.
Modern gene-editing tools may fuel that acceleration. By making precise cuts to DNA, geneticists insert or remove naturally occurring genes associated with specific traits. Some experts insist that gene editing has the potential to spark a new food revolution.
Jon Oatley, a reproductive biologist at Washington State University, wants to use Crispr-Cas9 to fine tune the genetic code of rugged, disease-resistant, and heat-tolerant bulls that have been bred to thrive on the open range. By disabling a gene called NANOS2, he says he aims to eliminate the capacity for a bull to make his own sperm, turning the recipient into a surrogate for sperm-producing stem cells from more productive prized stock. These surrogate sires, equipped with sperm from prize bulls, would then be released into range herds that are often genetically isolated and difficult to access, and the premium genes would then be transmitted to their offspring.
Furthermore, surrogate sires would enable ranchers to introduce desired traits without having to wrangle their herd into one place for artificial insemination, says Oatley. He envisions the gene-edited bulls serving herds in tropical regions like Brazil, the worlds largest beef exporter and home to around 200 million of the approximately 1.5 billion head of cattle on Earth.
Brazils herds are dominated by Nelore, a hardy breed that lacks the carcass and meat quality of breeds like Angus but can withstand high heat and humidity. Put an Angus bull on a tropical pasture and hes probably going to last maybe a month before he succumbs to the environment, says Oatley, while a Nelore bull carrying Angus sperm would have no problem with the climate.
The goal, according to Oatley, is to introduce genes from beefier bulls into these less efficient herds, increasing their productivity and decreasing their overall impact on the environment. We have shrinking resources, he says, and need new, innovative strategies for making those limited resources last.
Oatley has demonstrated his technique in mice but faces challenges with livestock. For starters, disabling NANOS2 does not definitively prevent the surrogate bull from producing some of its own sperm. And while Oatley has shown he can transplant sperm-producing cells into surrogate livestock, researchers have not yet published evidence showing that the surrogates produce enough quality sperm to support natural fertilization. How many cells will you need to make this bull actually fertile? asks Ina Dobrinski, a reproductive biologist at the University of Calgary who helped pioneer germ cell transplantation in large animals.
But Oatleys greatest challenge may be one shared with others in the bioengineered cattle industry: overcoming regulatory restrictions and societal suspicion. Surrogate sires would be classified as gene-edited animals by the Food and Drug Administration, meaning theyd face a rigorous approval process before their offspring could be sold for human consumption. But Oatley maintains that if his method is successful, the sperm itself would not be gene-edited, nor would the resulting offspring. The only gene-edited specimens would be the surrogate sires, which act like vessels in which the elite sperm travel.
Even so, says Dobrinski, Thats a very detailed difference and Im not sure how that will work with regulatory and consumer acceptance.
In fact, American attitudes towards gene editing have been generally positive when the modification is in the interest of animal welfare. Many dairy farmers prefer hornless cowshorns can inflict damage when wielded by 1,500-pound animalsso they often burn them off in a painful process using corrosive chemicals and scalding irons. In a study published last year in the journal PLOS One, researchers found that most Americans are willing to consume food products from cows genetically modified to be hornless.
Still, experts say several high-profile gene-editing failures in livestock and humans in recent years may lead consumers to consider new biotechnologies to be dangerous and unwieldy.
In 2014, a Minnesota startup called Recombinetics, a company with which Van Eenennaams lab has collaborated, created a pair of cross-bred Holstein bulls using the gene-editing tool TALENs, a precursor to Crispr-Cas9, making cuts to the bovine DNA and altering the genes to prevent the bulls from growing horns. Holstein cattle, which almost always carry horned genes, are highly productive dairy cows, so using conventional breeding to introduce hornless genes from less productive breeds can compromise the Holsteins productivity. Gene editing offered a chance to introduce only the genes Recombinetics wanted. Their hope was to use this experiment to prove that milk from the bulls female progeny was nutritionally equivalent to milk from non-edited stock. Such results could inform future efforts to make Holsteins hornless but no less productive.
The experiment seemed to work. In 2015, Buri and Spotigy were born. Over the next few years, the breakthrough received widespread media coverage, and when Buris hornless descendant graced the cover of Wired magazine in April 2019, it did so as the ostensible face of the livestock industrys future.
But early last year, a bioinformatician at the FDA ran a test on Buris genome and discovered an unexpected sliver of genetic code that didnt belong. Traces of bacterial DNA called a plasmid, which Recombinetics used to edit the bulls genome, had stayed behind in the editing process, carrying genes linked to antibiotic resistance in bacteria. After the agency published its findings, the media reaction was swift and fierce: FDA finds a surprise in gene-edited cattle: antibiotic-resistant, non-bovine DNA, read one headline. Part cow, part bacterium? read another.
Recombinetics has since insisted that the leftover plasmid DNA was likely harmless and stressed that this sort of genetic slipup is not uncommon.
Is there any risk with the plasmid? I would say theres none, says Tad Sonstegard, president and CEO of Acceligen, a Recombinetics subsidiary. We eat plasmids all the time, and were filled with microorganisms in our body that have plasmids. In hindsight, Sonstegard says his teams only mistake was not properly screening for the plasmid to begin with.
While the presence of antibiotic-resistant plasmid genes in beef probably does not pose a direct threat to consumers, according to Jennifer Kuzma, a professor of science and technology policy and co-director of the Genetic Engineering and Society Center at North Carolina State University, it does raise the possible risk of introducing antibiotic-resistant genes into the microflora of peoples digestive systems. Although unlikely, organisms in the gut could integrate those genes into their own DNA and, as a result, proliferate antibiotic resistance, making it more difficult to fight off bacterial diseases.
The lesson that I think is learned there is that science is never 100 percent certain, and that when youre doing a risk assessment, having some humility in your technology product is important, because you never know what youre going to discover further down the road, she says. In the case of Recombinetics. I dont think there was any ill intent on the part of the researchers, but sometimes being very optimistic about your technology and enthusiastic about it causes you to have blinders on when it comes to risk assessment.
The FDA eventually clarified its results, insisting that the study was meant only to publicize the presence of the plasmid, not to suggest the bacterial DNA was necessarily dangerous. Nonetheless, the damage was done. As a result of the blunder,a plan was quashed forRecombinetics to raise an experimental herd in Brazil.
Backlash to the FDA study exposed a fundamental disagreement between the agency and livestock biotechnologists. Scientists like Van Eenennaam, who in 2017 received a $500,000 grant from the Department of Agriculture to study Buris progeny, disagree with the FDAs strict regulatory approach to gene-edited animals. Typical GMOs are transgenic, meaning they have genes from multiple different species, but modern gene-editing techniques allow scientists to stay roughly within the confines of conventional breeding, adding and removing traits that naturally occur within the species. That said, gene editing is not yet free from errors and sometimes intended changes result in unintended alterations, notes Heather Lombardi, division director of animal bioengineering and cellular therapies at the FDAs Center for Veterinary Medicine. For that reason, the FDA remains cautious.
Theres a lot out there that I think is still unknown in terms of unintended consequences associated with using genome-editing technology, says Lombardi. Were just trying to get an understanding of what the potential impact is, if any, on safety.
Bhanu Telugu, an animal scientist at the University of Maryland and president and chief science officer at the agriculture technology startup RenOVAte Biosciences, worries that biotech companies will migrate their experiments to countries with looser regulatory environments. Perhaps more pressingly, he says strict regulation requiring long and expensive approval processes may incentivize these companies to work only on traits that are most profitable, rather than those that may have the greatest benefit for livestock and society, such as animal well-being and the environment.
What company would be willing to spend $20 million on potentially alleviating heat stress at this point? he asks.
On a windy winter afternoon, Raluca Mateescu leaned against a fence post at the University of Floridas Beef Teaching Unit while a Brahman heifer sniffed inquisitively at the air and reached out its tongue in search of unseen food. Since 2017, Mateescu, an animal geneticist at the university, has been part of a team studying heat and humidity tolerance in breeds like Brahman and Brangus (a mix between Brahman and Angus cattle). Her aim is to identify the genetic markers that contribute to a breeds climate resilience, markers that might lead to more precise breeding and gene-editing practices.
In the South, Mateescu says, heat and humidity are a major problem. That poses a stress to the animals because theyre selected for intense productionto produce milk or grow fast and produce a lot of muscle and fat.
Like Nelore cattle in South America, Brahman are well-suited for tropical and subtropical climates, but their high tolerance for heat and humidity comes at the cost of lower meat quality than other breeds. Mateescu and her team have examined skin biopsies and found that relatively large sweat glands allow Brahman to better regulate their internal body temperature. With funding from the USDAs National Institute of Food and Agriculture, the researchers now plan to identify specific genetic markers that correlate with tolerance to tropical conditions.
If were selecting for animals that produce more without having a way to cool off, were going to run into trouble, she says.
There are other avenues in biotechnology beyond gene editing that may help reduce the cattle industrys footprint. Although still early in their development, lab-cultured meats may someday undermine todays beef producers by offering consumers an affordable alternative to the conventionally grown product, without the animal welfare and environmental concerns that arise from eating beef harvested from a carcass.
Other biotech techniques hope to improve the beef industry without displacing it. In Switzerland, scientists at a startup called Mootral are experimenting with a garlic-based food supplement designed to alter the bovine digestive makeup to reduce the amount of methane they emit. Studies have shown the product to reduce methane emissions by about 20 percent in meat cattle, according to the New York Times.
In order to adhere to the Paris climate agreement, Mootrals owner, Thomas Hafner, believes demand will grow as governments require methane reductions from their livestock producers. We are working from the assumption that down the line every cow will be regulated to be on a methane reducer, he told the New York Times.
Meanwhile, a farm science research institute in New Zealand, AgResearch, hopes to target methane production at its source by eliminating methanogens, the microbes thought to be responsible for producing the greenhouse gas in ruminants. The AgResearch team is attempting to develop a vaccine to alter the cattle guts microbial composition, according to the BBC.
Genomic testing may also allow cattle producers to see what genes calves carry before theyre born, according to Mateescu, enabling producers to make smarter breeding decisions and select for the most desirable traits, whether it be heat tolerance, disease resistance, or carcass weight.
Despite all these efforts, questions remain as to whether biotech can ever dramatically reduce the industrys emissions or afford humane treatment to captive animals in resource-intensive operations. To many of the industrys critics, including environmental and animal rights activists, the very nature of the practice of rearing livestock for human consumption erodes the noble goal of sustainable food production. Rather than revamp the industry, these critics suggest alternatives such as meat-free diets to fulfill our need for protein. Indeed, data suggests many young consumers are already incorporating plant-based meats into their meals.
Ultimately, though, climate change may be the most pressing issue facing the cattle industry, according to Telugu of the University of Maryland, which received a grant from the Bill and Melinda Gates Foundation to improve productivity and adaptability in African cattle. We cannot breed our way out of this, he says.
This article was originally published on Undark. Read the original article.
Image Credit: RitaE from Pixabay
Read the rest here:
Biotechnology Could Change the Cattle Industry. Will It Succeed? - Singularity Hub
- Stem cells | Health Sciences - University of Minnesota [Last Updated On: August 22nd, 2014] [Originally Added On: August 22nd, 2014]
- Stem Cell FAQs - MED - Stem Cell Institute, University of ... [Last Updated On: August 22nd, 2014] [Originally Added On: August 22nd, 2014]
- Home - MED - Stem Cell Institute, University of Minnesota [Last Updated On: August 22nd, 2014] [Originally Added On: August 22nd, 2014]
- Minnesota Stem Cell Therapy | Stem Cell Treatments [Last Updated On: August 29th, 2014] [Originally Added On: August 29th, 2014]
- Researchers find animal model for understudied type of muscular dystrophy [Last Updated On: August 30th, 2014] [Originally Added On: August 30th, 2014]
- Cancer Survivor Saved by Measles Virus Raises Funds for Expanded Trial [Last Updated On: September 12th, 2014] [Originally Added On: September 12th, 2014]
- New heart built with stem cells - YouTube [Last Updated On: September 27th, 2014] [Originally Added On: September 27th, 2014]
- Becoming a blood stem cell or bone marrow donor ... [Last Updated On: October 3rd, 2014] [Originally Added On: October 3rd, 2014]
- $25M gift prompts University pediatric hospital name change [Last Updated On: October 16th, 2014] [Originally Added On: October 16th, 2014]
- Anti-Cancer Drug Effective Against Common Stem Cell Transplant Complication [Last Updated On: October 24th, 2014] [Originally Added On: October 24th, 2014]
- Mayo Clinic Researchers Identify First Steps in Formation of Pancreatic Cancer [Last Updated On: November 10th, 2014] [Originally Added On: November 10th, 2014]
- Cardio3 BioSciences Announces the Nomination of Three Co-Principal Investigators for Its CHART-2 Phase III Clinical ... [Last Updated On: November 28th, 2014] [Originally Added On: November 28th, 2014]
- Reduction of germ cells yields more zebrafish males [Last Updated On: December 4th, 2014] [Originally Added On: December 4th, 2014]
- Stem Cell Malaysia Blog [Last Updated On: December 12th, 2014] [Originally Added On: December 12th, 2014]
- Childrens hospital gets $25M [Last Updated On: December 16th, 2014] [Originally Added On: December 16th, 2014]
- Family: Experimental stem-cell treatment does wonders for Gordie Howe [Last Updated On: December 20th, 2014] [Originally Added On: December 20th, 2014]
- Stem Cell Web Focus - Nature Publishing Group : science ... [Last Updated On: February 3rd, 2015] [Originally Added On: February 3rd, 2015]
- Jakub Tolar, M.D., Ph.D. - MED - Stem Cell Institute ... [Last Updated On: February 24th, 2015] [Originally Added On: February 24th, 2015]
- Bioelectricity Plays Key Role in Brain Development & Repair [Last Updated On: March 13th, 2015] [Originally Added On: March 13th, 2015]
- Atsushi Asakura, Ph.D. - MED - Stem Cell Institute ... [Last Updated On: March 18th, 2015] [Originally Added On: March 18th, 2015]
- Graduate Programs - MED - Stem Cell Institute, University ... [Last Updated On: April 26th, 2015] [Originally Added On: April 26th, 2015]
- Minnesota Man With ALS Hopes Stem Cells Save His Life ... [Last Updated On: July 2nd, 2015] [Originally Added On: July 2nd, 2015]
- 2. Bone Marrow (Hematopoietic) Stem Cells [Stem Cell ... [Last Updated On: October 19th, 2015] [Originally Added On: October 19th, 2015]
- Multipotent vs. pluripotent stem cells - Pathology Student [Last Updated On: October 19th, 2015] [Originally Added On: October 19th, 2015]
- Home - Minnesota Regenerative Medicine [Last Updated On: August 18th, 2016] [Originally Added On: August 18th, 2016]
- Stem Cell Treatment - Minnesota Regenerative Medicine [Last Updated On: August 18th, 2016] [Originally Added On: August 18th, 2016]
- STEM Programs - Minnesota Zoo [Last Updated On: September 5th, 2016] [Originally Added On: September 5th, 2016]
- Minnesota to resume umbilical cord blood donations ... [Last Updated On: September 20th, 2016] [Originally Added On: September 20th, 2016]
- Minnesota invests in regenerative medicine - Health Talk [Last Updated On: October 7th, 2016] [Originally Added On: October 7th, 2016]
- Stem Cell FAQs - Minnesota Regenerative Medicine [Last Updated On: October 7th, 2016] [Originally Added On: October 7th, 2016]
- Stem cell research Experts@Minnesota [Last Updated On: October 18th, 2016] [Originally Added On: October 18th, 2016]
- Minnesotas Funding of Stem Cell Research Echoes Trend ... [Last Updated On: October 29th, 2016] [Originally Added On: October 29th, 2016]
- Stemonix, a stem cell research firm, wins Minnesota Cup ... [Last Updated On: November 27th, 2016] [Originally Added On: November 27th, 2016]
- Stem-cell clinics are using a federal website as a marketing tool for unproven treatments, U of M bioethicist says - MinnPost [Last Updated On: July 30th, 2017] [Originally Added On: July 30th, 2017]
- More than 60 US clinics have sold unproven stem cell therapies for heart failure - New York Post [Last Updated On: July 30th, 2017] [Originally Added On: July 30th, 2017]
- Cargill invests in 'clean meat' start-up - KARE [Last Updated On: August 24th, 2017] [Originally Added On: August 24th, 2017]
- Cowboy Up Ride Against Cancer - Wahpeton Daily News [Last Updated On: August 24th, 2017] [Originally Added On: August 24th, 2017]
- Mayo Clinic, University of Minnesota develop 'robocop' stem cells to fight cancer - Minneapolis Star Tribune [Last Updated On: August 24th, 2017] [Originally Added On: August 24th, 2017]
- FDA cracks down on stem cell clinics - CNN [Last Updated On: August 29th, 2017] [Originally Added On: August 29th, 2017]
- 2018 Regenerative Medicine Minnesota Research Awards [Last Updated On: August 17th, 2018] [Originally Added On: August 17th, 2018]
- The Promise of Stem Cells | Stem Cell Institute ... [Last Updated On: August 29th, 2018] [Originally Added On: August 29th, 2018]
- Stem-cell treatment gives two brothers a future ... [Last Updated On: March 3rd, 2019] [Originally Added On: March 3rd, 2019]
- Hoeven's bill supports alternative therapy for veterans with PTSD, traumatic brain injury - Ripon Advance [Last Updated On: October 1st, 2019] [Originally Added On: October 1st, 2019]
- Why Sangamo Therapeutics Stock Sank Today - The Motley Fool [Last Updated On: December 13th, 2019] [Originally Added On: December 13th, 2019]
- Coronavirus is similar to SARS and causes infection through a heart regulating enzyme: Study - International Business Times, Singapore Edition [Last Updated On: February 4th, 2020] [Originally Added On: February 4th, 2020]
- A word for those risking their lives amid the coronavirus crisis: Thanks - TwinCities.com-Pioneer Press [Last Updated On: April 4th, 2020] [Originally Added On: April 4th, 2020]
- Fate Therapeutics Announces First Patient Treated in First-in-human Clinical Trial of FT596 and Provides Corporate Update - Yahoo Finance [Last Updated On: April 4th, 2020] [Originally Added On: April 4th, 2020]
- University of Minnesota launches stem cell trial against severe COVID-19 - Minneapolis Star Tribune [Last Updated On: August 16th, 2020] [Originally Added On: August 16th, 2020]
- University of Minnesota launches stem cell trial against ... [Last Updated On: August 16th, 2020] [Originally Added On: August 16th, 2020]
- Coronavirus Thursday update: UMN announces new stem cell ... [Last Updated On: August 16th, 2020] [Originally Added On: August 16th, 2020]
- Berks County's first STEM-themed attraction opens, delights visitors young and old - Reading Eagle [Last Updated On: October 7th, 2020] [Originally Added On: October 7th, 2020]
- NMDP/Be The Match partners with M Health Fairview and Duke University cryopreservation labs to launch Be The Match BioBank - Watauga Democrat [Last Updated On: October 7th, 2020] [Originally Added On: October 7th, 2020]
- COVID-19 and the trials of treatment | News, Sports, Jobs - Escanaba Daily Press [Last Updated On: October 16th, 2020] [Originally Added On: October 16th, 2020]
- Negrin Shines Light on the Orca-T Story in GVHD - OncLive [Last Updated On: December 11th, 2020] [Originally Added On: December 11th, 2020]
- Our View: The need is vast. Consider becoming an organ donor. - PostBulletin.com [Last Updated On: August 18th, 2021] [Originally Added On: August 18th, 2021]
- EDITORIAL: The need is vast. Consider becoming an organ donor. - Yahoo News [Last Updated On: August 18th, 2021] [Originally Added On: August 18th, 2021]
- Caribou Biosciences Appoints Biotechnology Industry Veteran Ran Zheng to its Board of Directors - Stockhouse [Last Updated On: October 5th, 2021] [Originally Added On: October 5th, 2021]
- Four-year-old with rare disease finally gets historic gene therapy treatment - KARE11.com [Last Updated On: October 5th, 2021] [Originally Added On: October 5th, 2021]
- Cells or drugs? The race to regenerate the heart - Scientific American [Last Updated On: November 8th, 2021] [Originally Added On: November 8th, 2021]
- Induced Pluripotent Stem Cells and Their Potential for ... [Last Updated On: November 22nd, 2021] [Originally Added On: November 22nd, 2021]
- Minnesota woman reunites with teenager she saved through Be The Match transplant - KSTP [Last Updated On: April 19th, 2022] [Originally Added On: April 19th, 2022]
- Be the Match is looking for more ethnically diverse donors to help patients with blood cancers and diseases - KARE11.com [Last Updated On: June 4th, 2022] [Originally Added On: June 4th, 2022]
- Bluebird's future in balance as FDA weighs gene therapy approvals - BioPharma Dive [Last Updated On: June 13th, 2022] [Originally Added On: June 13th, 2022]
- Life-saving lecture: Auburn student uses lessons from class to help discover father's brain tumor - Office of Communications and Marketing [Last Updated On: June 22nd, 2022] [Originally Added On: June 22nd, 2022]
- Pluripotent stem cellderived NK cells with high-affinity noncleavable ... [Last Updated On: July 3rd, 2022] [Originally Added On: July 3rd, 2022]
- TC BioPharm Announces Formation of Scientific Advisory Board with Renowned Cell Therapy Experts - GuruFocus.com [Last Updated On: July 11th, 2022] [Originally Added On: July 11th, 2022]
- Witt Wolfpack: Family works out fundraising and awareness after La Jollan's ALS diagnosis - La Jolla Light [Last Updated On: July 11th, 2022] [Originally Added On: July 11th, 2022]
- Accelerating Transformational Research into Cell Transplantation for Patients with Type 1 Diabetes - UCSF [Last Updated On: July 27th, 2022] [Originally Added On: July 27th, 2022]
- Engineers develop new tool that will allow for more personalized cell therapies - UMN News [Last Updated On: July 27th, 2022] [Originally Added On: July 27th, 2022]
- University of Minnesota scientist responds to fraud allegations in Alzheimer's research - Star Tribune [Last Updated On: July 27th, 2022] [Originally Added On: July 27th, 2022]
- Gamida Cell Announces Dosing of First Patient in Company-Sponsored Phase 1/2 Study of NK Cell Therapy Candidate GDA-201 - Business Wire [Last Updated On: August 14th, 2022] [Originally Added On: August 14th, 2022]
- Kyle Vining: Appointment to Faculty of Penn Dental Medicine and Penn School of Engineering and Applied Science - University of Pennsylvania [Last Updated On: August 22nd, 2022] [Originally Added On: August 22nd, 2022]
- Zhang and colleagues win an $11.2 million NIH program project grant (PPG) - News - University of Alabama at Birmingham [Last Updated On: August 22nd, 2022] [Originally Added On: August 22nd, 2022]
- What Are Zombie Cells? Here's How They Impact Aging - Prevention Magazine [Last Updated On: September 8th, 2022] [Originally Added On: September 8th, 2022]
- ThreeSixty Journalism: Be The Match works to build equity in access to bone marrow and cord blood transplants - St. Paul Pioneer Press [Last Updated On: September 8th, 2022] [Originally Added On: September 8th, 2022]
- A history of blood cancer treatment - - pharmaphorum [Last Updated On: September 16th, 2022] [Originally Added On: September 16th, 2022]
- A CRISPR Alternative for Correcting Mutations That Sensitize Cells to DNA Damage - The Scientist [Last Updated On: October 13th, 2022] [Originally Added On: October 13th, 2022]
- The Switch to Regenerative Medicine - Dermatology Times [Last Updated On: October 13th, 2022] [Originally Added On: October 13th, 2022]
- Stem cell treatment after spinal cord injury: The next steps - Mayo Clinic [Last Updated On: December 18th, 2022] [Originally Added On: December 18th, 2022]